Last week, an article in the Journal of the American College of Radiology discussed an effort to eliminate the words ‘gross’ and ‘grossly’ from reports because of their multiple meanings. However, an excerpt from a report on General Surgery News’ blog may just take the cake for ambiguity.

Better outcomes can be achieved for prostate cancer patients using brachytherapy, a highly targeted form of radiotherapy, compared to surgery - this is the finding of a new study conducted by PANAXEA, The University of Twente, Netherlands.

Elekta (NSE: EKTAb) and Royal Philips Electronics (NYSE: PHG, AEX: PHIA) announced today that The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL, Amsterdam, the Netherlands) has signed an agreement to join a research group to advance the development of ground-breaking image-guided treatment technology for cancer care.

Leading research institutions are making breakthroughs in advanced MR imaging with Toshiba America Medical Systems, Inc.’s Vantage Titan™ 3T MR system. Toshiba has partnered with Shands at the University of Florida and the Keck Medical Center of the University of Southern California (USC) for MR research in fMRI, as well as body and cardiac imaging.

At the International Society for Magnetic Resonance in Medicine’s (ISMRM) 21st Annual Meeting & Exhibition in Salt Lake City, Royal Philips Electronics (NYSE: PHG, AEX: PHIA) today demonstrated a range of clinical functionalities in Magnetic Resonance Imaging (MRI)*, raising the bar on clinical excellence through greater collaboration, integration and increased patient focus.

Beaumont Hospital, Grosse Pointe has opened a new lung nodule clinic to provide early diagnosis and treatment of abnormal pulmonary nodules. Pulmonary nodules are a round or oval-shaped growth in the lung, sometimes referred to as a coin lesion or “spot” on the lung.

Exact Sciences has developed a stool-based screening test that detected 92 percent of cancers found on colonoscopy and 42 percent of precancerous polyps. The results fell shy of the company’s goal of a 50 percent polyp detection rate, according to an article in the New York Times; however, Exact Sciences indicated its plans to file for FDA approval of its Cologuard test.

Nearly 2,000 U.S. troops have had to undergo an amputation due to injuries sustained in Iraq or Afghanistan since the respective starts of those conflicts. While each of those injuries is gruesome and tragic, the advances in medicine brought about by their treatment are making their way back home and stand to help victims of the bombings at the Boston Marathon, according to an AP report.